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Abstract
Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disease with high penetrance, manifest by
brain hemorrhages in young normotensive adults. In Iceland, this condition is caused by the L68Q mutation in the cystatin C
gene, with contemporary carriers reaching an average age of only 30 years. Here, we report, based both on linkage
disequilibrium and genealogical evidence, that all known copies of this mutation derive from a common ancestor born
roughly 18 generations ago. Intriguingly, the genealogies reveal that obligate L68Q carriers born 1825 to 1900 experienced
a drastic reduction in life span, from 65 years to the present-day average. At the same time, a parent-of-origin effect
emerged, whereby maternal inheritance of the mutation was associated with a 9 year reduction in life span relative to
paternal inheritance. As these trends can be observed in several different extended families, many generations after the
mutational event, it seems likely that some environmental factor is responsible, perhaps linked to radical changes in the life-
style of Icelanders during this period. A mutation with such radically different phenotypic effects in reaction to normal
variation in human life-style not only opens the possibility of preventive strategies for HCCAA, but it may also provide novel
insights into the complex relationship between genotype and environment in human disease.
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Introduction
Amyloid deposits are found in various diseases, both genetic and
sporadic, such as Alzheimer’s disease and the prionoses [1].
HCCAA (MIM #105150) has so far only been found in Iceland
and it was the first to be described of a group of diseases called
hereditary cerebral amyloid angiopathies, characterized by
amyloid deposition in brain arteries [2,3]. The cystatin C gene
encodes an extracellular proteinase inhibitor with activity against
cysteine proteases of the papain and legumain family [4]. The
cystatin C L68Q mutation [5,6] is highly penetrant and the disease
is manifest by an intracerebral hemorrhage (ICH) in young
normotensive adults. The ICH is recurrent if the patient survives
the first attack and then commonly associated with dementia of
variable severity and/or paralysis, leading to death at 30.7 years of
age, on average (based on 130 individuals born after 1900 with life
spans ranging from 15 to 79 years). Cystatin C is the predominant
component [7] of the amyloid which is found in the cerebral
arterioles of patients [8]. In addition, wild-type cystatin C is found
in amyloid deposits with the Ab peptide in Alzheimer’s patients,
modulating cerebral b-amylodosis [9–11]. Furthermore, the
cystatin C locus (CST3) is one of the candidate susceptibility loci
for sporadic Alzheimer’s disease [12].
In the present study we collected data on patients diagnosed
with HCCAA, traced their family trees and found a progressive
reduction in the life span of patients and obigate carriers of the
disease mutation in addition to a parent-of-origin effect.
Results
Families
Overall, 15 families were identified with 266 known or inferred
carriers of the L68Q mutation. Figure 1 depicts the geographical
distribution of all 15 families around the year 1800 and Figure 2
shows an example pedigree for one extended family.
Age of the Mutation
The mean uncorrected single marker estimate was 13.9
generations, which increased to 21.5 after applying the Luria-
Delbru¨ck correction for population growth rate (Table S1). Both
means are affected by several extreme values obtained for
microsatellites where founder alleles are still in very strong LD
with the L68Q mutation.
An analysis of all 20 microsatellites simultaneously, using the
DMLE+ software, yielded a single age estimate of 17.9 generations
(95% C.I. 10.9–28.5). This suggests that the mutation occurred on
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a chromosome carried by an individual born around the mid 16th
century, presumably in Iceland.
Earliest Ancestor
We could not find the common ancestor of all the families using
genealogy due to lack of data. However, the earliest known
common ancestor was a man, born in 1684 in region B, who
moved and founded the two Southern families in region C (see
Figure 1).
Studies of Life Span
As premature death is such a striking phenotypic feature of the
L68Q mutation in confirmed carriers, we next attempted to
determine whether their ancestors carrying the mutation also had
reduced life span. First, we examined only the 157 confirmed
carriers, using their spouses as controls with the rationale that they
originated from the same regions [13], show a similar distribution
of birth years and led similar lifestyles as the mutation carriers.
The dependence of life span on the year of birth was studied by
linear regression models including polynomial terms. This analysis
revealed that the life span of L68Q carriers, both men and women,
underwent a significant reduction (P#2.2*10216) during the 19th
century (Figure 3A and Table 1). This life span reduction is
evident in the pedigrees, an example of which is shown in Figure 2.
In comparison, we found no change in the life span of the spouses
(n = 84) during this period (b=0.093, P#0.1232, Figure 3B). The
reduction in life span of L68Q carriers, compared to controls,
became evident in individuals born 1825 and after, following a
sigmoid curve showing a continuous decrease that leveled out at
the present average at the beginning of the 20th century
(P#3.3*10213, Figure 3C).
A similar reduction in life span was seen in a separate analysis of
the assumed carrier group (Figure 4A), whose spouses (n = 31) had
a slight but insignificant increase in life span (Figure 4B), thus
supporting the notion that those six families were also bona fide
HCCAA families. However, due to increasing early death of
carriers in the 20th century the L68Q mutation has now become
extinct in these families and in five of the nine families where
carrier status could be confirmed with genotyping.
Figure 1. A map of Iceland demonstrating the geographical distribution of families with the HCCAA mutation around the year
1800. Families were distributed in three regions denoted A, B, and C. Circles indicate families from which individuals have been DNA diagnosed and
triangles indicate families without DNA diagnosis.
doi:10.1371/journal.pgen.1000099.g001
Author Summary
This work focuses on the L68Q mutation in the cystatin C
gene which causes hereditary cystatin C amyloid angiop-
athy (HCCAA), an autosomal dominant disease with high
penetrance in contemporary Icelanders, manifest by lethal
brain hemorrhages in young normotensive adults. On the
basis of both DNA haplotype and genealogical analyses,
we determined that all known copies of the L68Q
mutation derive from a common ancestor born roughly
18 generations ago, around 1550. Furthermore, we were
able to show a rapid change in its penetrance for obligate
carriers born from 1825 to 1900, demonstrated by a drastic
reduction in life span, from 65 years to the present-day
average of 30 years. The detrimental phenotypic impact of
the L68Q mutation appears to have emerged in reaction to
common life-style changes almost three centuries after the
mutation occurred. We believe that this is the first report
of phenotypic flexibility of a monogenic disease in reaction
to life-style changes that fall within the normal range of
behavior of a single population in the space of a few
generations. Our results underline how single gene
disorders with simple Mendelian inheritance can be
affected by environmental factors, resulting in changed
disease status.
Life Span of Cystatin C L68Q Carriers
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Parent-of-Origin Effect
We observed a parent-of-origin effect on the life span of L68Q
carriers (Table 1) that is most notable for people born after 1900
(Figure 5). The data indicate that carriers who inherited the L68Q
mutation from their mother (n = 53; 29 sons and 24 daughters)
lived 27 years on average (standard deviation (S.D.) = 7.78),
whereas those who inherited the mutation from their father
(n = 51; 23 sons and 28 daughters) lived 36.4 years on average
(S.D. = 11.44). This 9.4 year difference in life span is highly
significant (t-test, P#0.001). It should be noted that of the handful
of mutation carriers born after 1900 (1–2%) who achieved a
‘‘normal’’ life span [14], all inherited the mutation from their
father.
Geographic Difference in Life Span
A significant difference (P#0.0016) was seen in the timing of life
span reduction between carriers from the remote Northwest
coastal region A and those from the South and West regions B and
C combined (Figures 1 and 6, and Table 1). The life span
reduction in region A was delayed by about 20 years compared to
the other regions.
Discussion
In this study of HCCAA families with the cystatin C L68Q
mutation we show that the life span of L68Q carriers in all the
families underwent a reduction in the 19th century reaching the
present day average of 30 years around 1900. Concurrently a
parent-of-origin effect became evident whereby those who
inherited the disease gene from the mother had, on average, a
9.4 years shorter life span compared to those who inherited it from
the father.
How can we account for the rather drastic reduction in the life
span of L68Q carriers that seems to have occurred three centuries
after the mutation arose? It is unlikely that this is due to an
additional, but currently undocumented, mutation acting as a
modifier of the risk conferred by the L68Q mutation. Indeed, an
additional mutation would need to have occurred many times in
several different extended families. Alternatively, and even less
plausible, a putative modifier mutation would have needed to
spread from very low frequency to near fixation in each of the
L68Q carrier families in the space of a few generations. Rather, we
postulate the involvement of some environmental factor that came
into play around 1825 and reached saturation around 1900,
possibly a dietary factor such as the increased consumption of
carbohydrates (Figure 7) or salt (for food preservation). The notion
of an environmental modifier of disease risk conferred by the
L68Q mutation is supported by the observation that the decrease
in life span was delayed by about 20 years in the remote Northwest
coastal region A compared to the West and South regions B and C
combined. Thus, the life-style changes associated with economic
development in Iceland during the 19th century occurred later in
remote regions than in regions closer to the capital Reykjavik.
It is interesting that in the same time period (the 19th century) a
parent-of-origin effect of the L68Q mutation is seen in the context
of the life span reduction of carriers. This could be explained by a
transgenerational epigenetic mechanism [15], such as the one
described for the agouti viable yellow mutation in mice [16,17]
where the frequency of disease in offspring can be changed with
dietary methyl supplementation of pregnant dams. However,
although cystatin C has a large CpG region in the promoter, the
gene is not known to be a metastable epiallele or reside in a known
imprinting region.
The conclusion that environmental factors alter the phenotypic
impact of mutations underlying serious heritable disorders is not
novel. A classic example is the dietary treatment of phenylketouria
(PKU) patients to prevent cognitive damage [18]. What is unusual
about the findings reported here is rather that the detrimental
phenotypic impact of the L68Q mutation appears to have
emerged in reaction to life-style changes that fall within the
normal range of behavior of a single population in the space of a
few generations. Even this may not be without parallel, as a
reduced life span over time coupled with a maternal effect has also
been described in another familial amyloid disease in Sweden, i.e.
FAP (familial amyloidotic polyneuropathy) which is caused by a
mutation (V30M) in the transthyretin gene [19]. Such diseases
challenge simplistic views of Mendelian diseases as solely genetic in
nature and insensitive to environmental factors. An understanding
of the phenotypic flexibility of the L68Q mutation might provide
the possibility for preventive or therapeutic strategies to deal with
HCCAA. Such an understanding may also be relevant to other
common but pathophysiologically related disorders such as
Alzheimer’s disease, where cerebral amyloid angiopathy (CAA)
is very common. Finally it may also present an opportunity for
more general insights into the complex relationship between
genotype and environment in human disease.
Materials and Methods
Family Data
A total of 36 individuals from nine families with known histories
of ICH were diagnosed as carriers of the L68Q mutation through
Figure 2. One of the HCCAA pedigrees. Women are depicted as circles, men as squares. The year of birth and life span (in brackets) are shown
beneath the symbols. Triangles indicate children that died as infants; their number is indicated beside the triangle. Obligate mutation carriers are
labeled with a central dot and diagnosed individuals (brain hemorrhage according to death certificates/parish records) are shown as filled symbols.
As expected for a dominant disease, about half of the sib-groups are carriers on average. Within this pedigree only individuals V-II and VI-I were DNA
diagnosed.
doi:10.1371/journal.pgen.1000099.g002
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direct genotyping [6]. The ancestors of these individuals were
found by tracing pedigrees, either with the help of Arnason [3],
published pedigrees [20], or with the deCODE Genetics
genealogy database that contains information about the relation-
ships between 740.000 Icelanders, past and present [13]. Ancestors
who were obligate carriers of L68Q were defined as parents or
common ancestors of known carriers whose inferred carrier status
minimizes the number of transmission events of the mutation in
the genealogies. For most individuals, the only available
phenotypic information was age at death, as the first signs of
HCCAA can be subtle such as personality changes and dementia.
Death certificates (first issued in Iceland in 1911) and parish
records were also checked and the cause of death was noted when
known. The year of birth, and death, of spouses of obligate L68Q
carriers were noted when available.
The nine extended families thus defined contain 202 individ-
uals, including 92 ancestors who are obligate carriers. Although
the cause of death for these obligate carriers was often consistent
with ICH, we also included those who died from other causes such
as drowning or infections. In some cases, family members with no
offspring or contemporary descendants were defined as obligate
carriers, when their death certificate (n = 61) or their parish record
(n= 17) indicated brain hemorrhage. Individuals were excluded if
no information was available about cause of death. Limiting the
Figure 3. Families with DNA diagnosis. (A) Relationship between the life span of L68Q mutation carriers (n = 157) and their year of birth from the
year 1800 to 1940. The observed values for females are denoted with open circles, males with filled circles. The expected values, from a polynomial
regression, for females and males are shown with a dashed, and a solid line, respectively. The difference among the genders was not significant. (B)
Relationship between the life span of 86 spouses of L68Q mutation carriers in families with DNA diagnosis and their year of birth. The line represents
the fitted relationship from a linear regression (b= 0.093, P,0.1232, R2= 0.03). It should be noted that these individuals represent adults that reached
child-bearing age; the figure, therefore, does not reflect the relatively high infant/child mortality rate of the period. (C) Difference in life-span of
obligate gene carriers (n = 72), compared to the spouses group (n = 86), in relation to the birth year of the carriers. The line presents the expectation
from a polynomial regression (R2=0.59). The expectancy of life span during the study period was estimated by a regression of life span of spouses on
their birth year (B). The reduction in life span of a carrier, considering his/her birth year, was calculated as the deviation from this line.
doi:10.1371/journal.pgen.1000099.g003
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analyses to all carriers born before 1940 (to exclude those who
have an exceptionally long life span) we hereafter refer to 157
carriers as the confirmed carrier group.
In addition to the aforementioned known and obligate carriers,
there are 34 deceased individuals who are strongly suspected of
having been carriers of the L68Q mutation, but for whom no DNA
samples were available. The inference of carrier status for these
individuals is based on death certificates (n= 17) and parish records
(n= 17) that indicate brain hemorrhage as the cause of death. Using
the same approach as before to trace obligate carrier ancestors, we
identified six new families and 30 new obligate carriers. We refer to
this set of 64 individuals as the assumed carrier group.
Age of the Mutation
In order to gain insight into the history of the cystatin C L68Q
mutation in the Icelandic gene pool, we estimated its age by
examining the decay of linkage disequilibrium (LD) between it and
20 surrounding microsatellites in the 36 known carriers and 722
non-carrier controls. The microsatellites spanned the physical map
positions 14.7–38.3 Mb (NCBI build 35) on chromosome 20, with
the L68Q mutation located at position 23,563,968 (see Table S1).
PCR amplifications were set up, run, and pooled on Gilson
Cyberlab robots. The reaction volume was 5 ml, and, for each
PCR, 20 ng of genomic DNA was amplified in the presence of
2 pmol of each primer, 0.25 U AmpliTaq Gold, 0.2 mM dNTPs,
and 2.5 mM MgCl2 (buffer was supplied by the manufacturer,
Table 1. The effect of year of birth, fitted with a polynomial
regression, and the geographical and genetic (maternal/
paternal) origin on the lifespan of carriers.
DF MS F P
Birth Year (3) 3 6622.2 43.705 2.2*10–16
Geographical origin 1 1563.3 10.317 0.0016
Genetic origin 1 1242.1 8.197 0.0048
Residuals 145 151.5
DF, MS, and F signify degrees of freedom, mean square and F-statistic,
respectively.
doi:10.1371/journal.pgen.1000099.t001
Figure 4. Families without DNA diagnosis. (A)The relationship between the life span of L68Q mutation carriers (n = 64; assumed carrier group) in
families without DNA diagnosis and their year of birth between the years 1780 and 1920. The line presents the fitted relationship from a polynomial
regression (R2=0.68). (B) Relationship between the life span of 31 spouses of L68Q mutation carriers in families without DNA diagnosis and their year
of birth. The line represents the fitted relationship from a linear regression (b=0.076, P,0.494, R2= 0.02).
doi:10.1371/journal.pgen.1000099.g004
Figure 5. Relationship between the life span of L68Q mutation
carriers and their year of birth from the year 1800 to 1940. In
this case the data is categorized according to maternal/paternal
inheritance. Individuals that inherited the mutant gene from their
mother are shown as filled circles; individuals that inherited the gene
from their father are shown as open circles. Fitted lines from polynomial
regressions are shown for both categories. The dashed line shows the
expected values for individuals that inherited the gene from their
fathers, the solid line shows the expected values for individuals that
inherited the gene from their mothers.
doi:10.1371/journal.pgen.1000099.g005
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Applera). Cycling conditions were as follows: 95uC for 10 min,
followed by 37 cycles of 94uC for 15 s, annealing for 30 s at 55uC,
and 1 min extension at 72uC. One primer of each primer pair was
fluorescently labeled. The PCR products were pooled into panels
of 8–16 markers, mixed with size standards, and analyzed on ABI
3700 sequencing machines using Genescan (version 3.0) peak-
calling software (Applied Biosystems, Foster City, CA). Alleles
were automatically called using DAC, an allele-calling program
developed at deCODE Genetics [21], and the program Deco-
deGT was used to fractionate called genotypes, according to
quality, and to edit when necessary [22].
First, we established the microsatellite allele states of the
chromosome on which the L68Q mutation is most likely to have
occurred, referred to hereafter as the founder alleles. This was
achieved by picking the microsatellite allele that exhibited the
strongest LD (measured by D’) with the cystatin C mutation and
showed the greatest difference in frequency between the mutation
carriers and controls. Haplotype frequencies were estimated using
the expectation maximization (EM) algorithm [23]. Age estimates
of the mutation were then obtained based on the pattern of LD
with each individual microsatellite based on the formula:
t~
1
ln 1{hð Þ ln
x tð Þ{y
1{y
 
where t is the age of the mutation in generations, h is the
recombination rate in Morgans between the mutation and the
flanking microsatellite, x(t) is the frequency of chromosomes
carrying both the cystatin C mutation and the microsatellite
ancestral allele and y is the frequency of chromosomes that do not
carry the cystatin C mutation but do carry the microsatellite
ancestral allele [24]. Age estimates based on individual microsat-
ellites were also calculated using a correction, based on the Luria-
Delbru¨ck model, that takes into account the impact of population
growth [25]. The corrected age is defined as:
t^~tz { 1=rð Þln he
r
er{1
  
Figure 6. A comparison of the onset, and trend, of life span
reduction between two geographic regions. Filled circles are
individuals from the North-West of Iceland (region A in Figure 1), open
circles are individuals from the West and South of Iceland (regions B
and C in Figure 1). Fitted lines from polynomial regressions are shown
for both categories. The dashed lines show the expected values for
regions B and C combined, the solid line shows the expected values for
region A. The difference between these lines indicates an approximately
20 year delay in the onset of life span reduction in the North-West of
Iceland.
doi:10.1371/journal.pgen.1000099.g006
Figure 7. Changes in the percentage of dietary energy. Derived from fat (blue line), protein (red line), and carbohydrates (green line) in Iceland
from the year 1790–1940 (adapted from Jonsson [29]). Iceland was an isolated island with relatively little importation of food at the beginning of our
study period, which then underwent drastic changes of dietary habits during the latter part of the 19th century. Records of imported food items per
capita show a shift in the proportion of energy derived from carbohydrates from 25 % in 1840 to approximately 50 % in 1900; the proportion of
energy derived from fat and protein decreased accordingly.
doi:10.1371/journal.pgen.1000099.g007
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using the same notation as before with additional parameters, t,
the time estimate based on the previous formula, and r, the rate of
past exponential population growth per generation. Based on
detailed information about the size of the Icelandic population
during the past 250 years [26], we estimated r to have been 0.3.
The recombination rates between loci were obtained by
interpolating positions from the high-resolution recombination
map estimated from the phase II HapMap project data, using
physical map locations as the common frame of reference (www.
hapmap.org) [27].
As age estimates based on individual loci can be subject to
considerable measurement error, and are unreliable between
alleles that are still in very strong LD, we also employed the
method implemented in the DMLE+ software version 2.3 [28].
Using this approach we were able to use the LD pattern of all 20
microsatellites simultaneously with the L68Q mutation to provide
a single age estimate. The DMLE+ software was run using
100,000 burn-in iterations and 100,000 calculation iterations, with
r=0.3.
Web Resources
The URLs for data presented herein are as follows: Online
Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.
nih.gov/sites/omim.
Supporting Information
Table S1 Microsatellites used to estimate the age of the L68Q
mutation in the cystatin C gene.
Found at: doi:10.1371/journal.pgen.1000099.s001 (0.07 MB
DOC)
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